Inventor · disambiguated record
Katherine A. High
Also filed as: HIGH KATHERINE · HIGH KATHERINE A
28 granted patents·25 pending applications·406 citations·filing 1998–2023
96Inventor score
Files withCHILDRENS HOSPITAL PHILADELPHIA21PHILADELPHIA CHILDREN HOSPITAL10HIGH KATHERINE A4SPARK THERAPEUTICS INC4SANGAMO BIOSCIENCES INC3
Top patents by PatentIndex Score
53 records- 0197US9255250B2Isolated mouse or human cell having an exogenous transgene in an endogenous albumin geneSANGAMO BIOSCIENCES INC·Filed 2013·Granted Feb 9, 2016·67 cites·5 claims
- 0296US9840719B2Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissuesTHE CHILDREN'S HOSPITAL OF PHILADELPHIA·Filed 2014·Granted Dec 12, 2017·86 cites·21 claims
- 0395US11110153B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2020·Granted Sep 7, 2021·3 cites·28 claims
- 0493US10799566B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2016·Granted Oct 13, 2020·7 cites·64 claims
- 0592US9909142B2Composition and methods for highly efficient gene transfer using AAV capsid variantsCHILDRENS HOSPITAL PHILADELPHIA·Filed 2013·Granted Mar 6, 2018·24 cites·19 claims
- 0692US9629930B2Methods and compositions for treating hemophilia BSANGAMO BIOSCIENCES INC·Filed 2015·Granted Apr 25, 2017·8 cites·18 claims
- 0792US9408904B2Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyWRIGHT JOHN FRASER·Filed 2012·Granted Aug 9, 2016·22 cites·21 claims
- 0891US7998734B2Methods and compositions for use in gene therapy for treatment of hemophiliaPHILADELPHIA CHILDREN HOSPITAL·Filed 2007·Granted Aug 16, 2011·14 cites·8 claims
- 0990US11491213B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2021·Granted Nov 8, 2022·1 cites·33 claims
- 1090US9175280B2Methods and compositions for treating hemophilia BGREGORY PHILIP D·Filed 2011·Granted Nov 3, 2015·9 cites·11 claims
- 1189US10392632B2AAV8 vector with enhanced functional activity and methods of use thereofWRIGHT JOHN FRASER·Filed 2012·Granted Aug 27, 2019·18 cites·22 claims
- 1287US8071293B2PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosisHIGH KATHERINE A·Filed 2009·Granted Dec 6, 2011·34 cites·15 claims
- 1386US6093392AMethods and compositions for use in gene therapy for treatment of hemophiliaCHILDRENS HOSPITAL OF PHILDELP·Filed 1998·Granted Jul 25, 2000·75 cites·11 claims
- 1485US7220849B2Enhanced gamma-carboxylation of recombinant vitamin K-dependent clotting factorUNIV NORTH CAROLINA·Filed 2003·Granted May 22, 2007·25 cites·16 claims
- 1585US2024131126A1Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2023·Application pending·0 cites
- 1683US11896652B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2022·Granted Feb 13, 2024·0 cites·23 claims
- 1777US10448823B2Apparatus and methods for testing visual function and functional vision at varying luminance levelsCHILDRENS HOSPITAL PHILADELPHIA·Filed 2017·Granted Oct 22, 2019·4 cites·66 claims
- 1876US2022334126A1Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodiesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2022·Application pending·0 cites
- 1976US2020129598A1Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2019·Application pending·0 cites
- 2074US7211558B2Compositions and methods for the treatment of hemophilia APHILADELPHIA CHILDREN HOSPITAL·Filed 2003·Granted May 1, 2007·4 cites·9 claims
- 2172US2022387560A1Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular DiseaseSPARK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2271US8063022B1Methods for preventing formation of inhibitory antibodies in the setting of gene therapyHIGH KATHERINE A·Filed 2000·Granted Nov 22, 2011·5 cites·4 claims
- 2370US11878056B2Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2020·Granted Jan 23, 2024·0 cites·24 claims
- 2469US11559589B2Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2018·Granted Jan 24, 2023·0 cites·6 claims
- 2569US9075044B2Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapyHIGH KATHERINE A·Filed 2007·Granted Jul 7, 2015·0 cites·5 claims
- 2665US11408899B2AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodiesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2014·Granted Aug 9, 2022·0 cites·34 claims
- 2763US2007166283A1Compositions and methods for the treatment of hemophilia aHIGH KATHERINE A·Filed 2007·Application pending·0 cites
- 2862US11939590B1AAV vector compositions and methods for gene transfer to cells, organs and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2018·Granted Mar 26, 2024·0 cites·19 claims
- 2962US2019038724A1Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular DiseaseSPARK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3061US11279950B2Composition and methods for highly efficient gene transfer using AAV capsid variantsCHILDRENS HOSPITAL PHILADELPHIA·Filed 2018·Granted Mar 22, 2022·0 cites·17 claims
- 3161US2019321463A1Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2019·Application pending·0 cites
- 3260US11807865B2Large commercial scale lentiviral vector production system and vectors produced therebyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2018·Granted Nov 7, 2023·0 cites·18 claims
- 3358US2011263690A1Methods and Compositions for use in Gene Therapy for Treatment of HemophiliaPHILADELPHIA CHILDREN HOSPITAL·Filed 2011·Application pending·0 cites
- 3456US2015320886A1Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapyPHILADELPHIA CHILDREN HOSPITAL·Filed 2015·Application pending·0 cites
- 3555US10328145B2Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2016·Granted Jun 25, 2019·0 cites·24 claims
- 3655US2016346359A1Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular DiseaseSPARK THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3753US2004009151A1Methods for delivering recombinant adeno-associated virus virions to the liver of a mammalFiled 2003·Application pending·0 cites
- 3853US2018187213A1Variant AAV and Compositions, Methods and Uses for Gene Transfer to Cells, Organs and TissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2017·Application pending·0 cites
- 3952US2006188482A1Methods for delivering recombinant adeno-associated virus virions to the liver of a mammalKAY MARK A·Filed 2006·Application pending·0 cites
- 4052US2002106381A1Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virusFiled 2001·Application pending·0 cites
- 4152US2018273607A1Modified blood clotting factors and methods of useCHILDRENS HOSPITAL PHILADELPHIA·Filed 2018·Application pending·0 cites
- 4250US2011126303A1Modified Blood Clotting Factors And Methods Of UsePHILADELPHIA CHILDREN HOSPITAL·Filed 2010·Application pending·0 cites
- 4348US2015116667A1Apparatus and methods for testing visual function and functional vision at varying luminance levelsPHILADELPHIA CHILDREN HOSPITAL·Filed 2014·Application pending·0 cites
- 4447US2015111955A1Aav vector compositions and methods for gene transfer to cells, organs and tissuesPHILADELPHIA CHILDREN HOSPITAL·Filed 2013·Application pending·0 cites
- 4546US2003130221A1Induction of tolerance to a therapeutic polypeptidePHILADELPHIA CHILDREN HOSPITAL·Filed 2002·Application pending·0 cites
- 4645US2004102388A1Modified blood clotting factors and methods of useFiled 2001·Application pending·0 cites
- 4744US2016143953A1Methods and compositions for regulation of metabolic disordersSANGAMO BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 4844US2014349403A1Large commercial scale lentiviral vector production system and vectors produced therebyPHILADELPHIA CHILDREN HOSPITAL·Filed 2012·Application pending·0 cites
- 4943US2019192693A1Methods and vectors for treating cns disordersSPARK THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5043US2005281784A1Methods for administering recombinant adeno-associated virus virons to humans previously exposed to adeno-associated virusPHILADELPHIA CHILDREN HOSPITAL·Filed 2005·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Katherine A. High files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →